About Dual AAV
Dual AAV vectors split your gene into two vectors that under in-vivo homologous recombination, reforms to produce a full gene product. These are used when payloads >4.7kb are required.
Dual AAV vector controls contain two AAV vectors, with each vector carrying half of a GFP reporter gene. When recombined, a functional GFP is formed, allowing quick visual read-out.
Your team can use dual AAV vector controls to de-risk projects, for proof-of-principle studies, and to optimize parameters before moving into larger, more complex experiments. These controls are available in a wide range of promoters for tissue targeting.
Features
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
AAV-h-ANXA10-shRNA
Cat No: shAAV-201040
Availability: 4-5 weeks
AAV-h-ANXA11-shRNA
Cat No: shAAV-201041
Availability: 4-5 weeks
AAV-h-ANXA13-shRNA
Cat No: shAAV-201042
Availability: 4-5 weeks
AAV-h-ANXA2-shRNA
Cat No: shAAV-201043
Availability: 6-8 weeks
AAV-h-ANXA3-shRNA
Cat No: shAAV-201053
Availability: 4-5 weeks
AAV-h-ANXA4-shRNA
Cat No: shAAV-201056
Availability: 4-5 weeks
AAV-h-ANXA5-shRNA
Cat No: shAAV-201057
Availability: 4-5 weeks
AAV-h-ANXA6-shRNA
Cat No: shAAV-201062
Availability: 4-5 weeks
AAV-h-ANXA7-shRNA
Cat No: shAAV-201063
Availability: 4-5 weeks
AAV-h-ANXA8-shRNA
Cat No: shAAV-201064
Availability: 4-5 weeks
AAV-h-ANXA8L2-shRNA
Cat No: shAAV-201066
Availability: 6-8 weeks
AAV-h-ANXA9-shRNA
Cat No: shAAV-201067
Availability: 6-8 weeks
